TODAY'S HEADLINES

How Vermont aims to cut drug spending

If a proposed Vermont bill is successful, drug companies would have to explain why they hiked prices on certain drugs. Read more

Opdivo snags 2 new cancer approvals

Nivolumab (Opdivo, Bristol-Myers Squibb) received 2 new approvals from FDA to treat 2 different cancers. Read more

CONTINUING PHARMACY EDUCATION

Keep your patients moving: An overview of treatment options for constipation

This month's CE activity, "Keep your patient moving: An overview of treatment options for constipation," is open for pharmacists and pharmacy technicians.
The goal of this program is to assist pharmacists and pharmacy technicians in their understanding of the role of linaclotide, lubiprostone, methylnaltrexone, and naloxegol in the treatment of constipation after conventional nonpharmacologic interventions and conventional laxatives such as bulking agents, osmotic laxatives, and stimulant laxatives have failed.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

FDA warns about antibacterials

FDA issued a new warning about potentially serious side effects associated with fluoroquinolone antibacterial drugs. Find out which brand names and generics are affected. Read more

May 25, 2016

National Managed Care Pharmacy Survey 2016

Your input is needed! Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, is seeking your opinion on the current state of pharmacy. Take the survey and you could win a $200 Visa gift card. Answer Now.

Related Articles

Top 7 new facts about drug spending

Top 5 facts about new cancer drug